✦ LIBER ✦

Complexation of amphotericin B with egg phosphatidylcholine liposomes

✍ Scribed by Jin-Chul Kim; Eun-Ok Lee; Ji-Won Yang; Tae-Boo Choe; Jong-Duk Kim

Book ID: 112961761
Publisher: Springer
Year: 1995
Tongue: English
Weight: 517 KB
Volume: 18
Category: Article
ISSN: 0253-6269
DOI: 10.1007/bf02979139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amphotericin B-sterol complex formation

Amphotericin B-sterol complex formation and competition with egg phosphatidylcholine: a monolayer study

✍ M. Saint-Pierre-Chazalet; C. Thomas; M. Dupeyrat; C.M. Gary-Bobo 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 850 KB

Effect of amphotericin B on cholesterol-

Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranes

✍ P. Van Hoogevest; B. De Kruijff 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 699 KB

Bile salt damage of egg phosphatidylchol

Bile salt damage of egg phosphatidylcholine liposomes

✍ Charmian J. O'Connor; Robert G. Wallace; Kiyoshi Iwamoto; Takayuki Taguchi; Junz 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 642 KB

Amphotericin B: liposomal less costly th

Amphotericin B: liposomal less costly than lipid complex

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB

Clinical use of liposomal and lipid-comp

Clinical use of liposomal and lipid-complexed amphotericin B

📂 Article 📅 1994 🏛 Oxford University Press 🌐 English ⚖ 615 KB

Amphotericin B lipid complex versus lipo

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy

✍ Ray Y. Hachem; Maha R. Boktour; Hend A. Hanna; Rola N. Husni; Harrys A. Torres; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancy (HM). There are 2 lipid formulations of amphotericin B (AMB) currently in widespread use: AMB lipid complex (ABLC) and liposomal AMB (L‐AMB). There are limited